Virologic failure is uncommon after treatment initiation during acute HIV infection

Crowell, Trevor A.; Phanuphak, Nittaya; Pinyakorn, Suteeraporn; Kroon, Eugene; Fletcher, James L.K.; Colby, Donn; Tipsuk, Somporn; Karnsomlap, Putthachard; Laopraynak, Naphassanant; O’Connell, Robert J.; Robb, Merlin L.; Ananworanich, Jintanat

In chronic HIV infection, initiation of antiretroviral therapy (ART) typically induces swift HIV RNA declines and virologic suppression within 24 weeks. The objective of this study was to investigate viral dynamics and common criteria for treatment success after ART initiation during acute HIV infection (AHI).

August 29, 2016
Year of publication
Resource types
Journal and research articles, Reports and Fact sheets
chronic HIV infection, ART initiation, virologic suppression, treatment success, acute HIV infection, treatment, antiretroviral therapy, ART, ARVs, antiretroviral drugs

Similar Resources

HIV eradication and remission research has largely taken place in high-income countries. In low- and middle-income countries (LMIC), there may be factors that have a substantial impact on the size of the latent HIV reservoir and the immunological response to infection.

Lifelong ART is essential to reducing HIV mortality and ending the epidemic, however the interplay between socioeconomic position and long-term outcomes of HIV-infected persons receiving antiretroviral therapy (ART) in sub-Saharan Africa is unknown.

This supplement to Acta Paediatrica presents a series of meta-analyses and systematic literature reviews examining a variety of health effects potentially related to breastfeeding.

This issue of the Southern African HIV Clinicians Society's "HIV Nursing Matters" online magazine focuses on vulnerable populations, including TB in prisons and intimate partner violence in the context of HIV.

This issue of the Southern African HIV Clinicians Society's "HIV Nursing Matters" online magazine focuses on key populations.

This supplement of JAIDS provides a compilation of health promoters and their professional allies' experiences in the field of HIV care and prevention.

Higher baseline viral load, longer time to viral suppression and low-level viraemia below the level of detection of standard tests raise the risk of viral rebound amongst people with HIV on antiretroviral therapy (ART), according to a pair of…

Since WHO published the 2016 ARV guidelines, several studies have evaluated the safety and efficacy of dolutegravir (DTG) during pregnancy and the periconcep